University of Arizona researchers achieved nearly 90% accuracy in pancreatic cancer phenotyping using label-free optical microscopy with deep learning AI.
Key Details
- 1Label-free optical microscopy paired with deep neural networks identified tissue phenotypes at over 89% accuracy in pancreatic cancer samples.
- 2Spatial transcriptomics served as the 'ground truth' for phenotypic classification.
- 3Traditional image analysis could not match the performance of AI methods, pointing to AI's necessity in extracting meaningful features from label-free images.
- 4This approach bypasses expensive and time-intensive molecular/genetic sequencing currently used in precision medicine.
- 5The work demonstrates a significant step toward more accessible and rapid phenotyping for cancer care.
Why It Matters
This study advances the use of imaging AI in precision medicine by offering a faster, less costly method for cancer phenotyping. It highlights the potential for optical imaging and AI to broaden access to personalized care by reducing dependence on resource-heavy molecular diagnostics.
Source
EurekAlert
Related News
•EurekAlert
Study Warns: AI Alone Is Not Enough in Critical Healthcare Decisions
Evaluating both AI algorithms and human users is key for safe adoption in high-stakes healthcare settings, according to an Ohio State study.
•EurekAlert
AI Dramatically Improves Prediction of Delivery Timing from Ultrasound Images
Ultrasound AI's study validates advanced AI for predicting delivery timing using standard ultrasound images.
•EurekAlert
AI-Assisted Colonoscopies May Reduce Clinicians’ Detection Skills, Study Finds
Routine use of AI in colonoscopies linked to decreased skill in adenoma detection by clinicians without AI assistance.